$PFE Company News 10 stocks for the U.S. economy
Post# of 102095
10 stocks for the U.S. economy’s revival in 2014 10:14 a.m. Dec. 27, 2013 - Diana Furchtgott-Roth
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 11:12 a.m. Dec. 10, 2013 - blogs.marketwatch.com
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Auxilium shares soar after FDA approves drug for additional use 3:53 p.m. Dec. 6, 2013 - blogs.marketwatch.com
A tale of two drug companies 4:13 p.m. Dec. 5, 2013 - Mark Hulbert
3 low-risk stocks for market skeptics 6:15 a.m. Dec. 5, 2013 - Jeff Reeves
DuPont, Pfizer are top decliners in Dow index 4:01 p.m. Dec. 3, 2013 - Polya Lesova
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
China Halts Imports Of Pfizer Medication Diflucan 7:56 a.m. Today - WSJ.com
Actavis: The Growth Of Biotech With The Valuation Of Large Pharma 4:32 p.m. Dec. 30, 2013 - Seeking Alpha
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
One Put, One Call Option To Know About For Pfizer 12:21 p.m. Dec. 30, 2013 - TheStreet.com
Many Key Changes to Goldman Sachs Conviction Buy List for 2014 10:52 a.m. Dec. 30, 2013 - 247WallSt.com
Dogs of the Dow Won’t Hunt in 2014 7:51 a.m. Dec. 30, 2013 - InvestorPlace.com
Hold the Sizzle - Michael Price's Low P/E Stocks in Review 8:30 p.m. Dec. 28, 2013 - GuruFocus.com
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
Three S&P 500 and Dow Industrial Companies Report Dividend Growth and Buyback Extensions 5:20 p.m. Dec. 27, 2013 - GuruFocus.com
Is There Still Room To Profit With Halozyme? 12:52 p.m. Dec. 27, 2013 - Seeking Alpha
Best Stocks for 2014 12:39 a.m. Dec. 27, 2013 - Barrons.com
Pfizer Becomes #22 Most Shorted Dow Stock, Replacing Goldman Sachs Group 11:17 a.m. Dec. 26, 2013 - TheStreet.com
A Strong Sign for 2014 – Capital Spending vs Buybacks 4:00 a.m. Dec. 26, 2013 - InvestorPlace.com
Companies Binge on Share Buybacks 9:31 p.m. Dec. 25, 2013 - WSJ.com
Dividends: Big Dogs, Small Dogs And Spy Dogs 4:11 a.m. Dec. 25, 2013 - Seeking Alpha
Pipeline Progress at Athersys - Analyst Blog 5:20 p.m. Dec. 24, 2013 - Zacks.com
Update on Glaxo's HIV Drugs - Analyst Blog 4:30 p.m. Dec. 24, 2013 - Zacks.com
AT&T and Pfizer Top GuruFocus Dividend Growers of the Week 11:28 a.m. Dec. 24, 2013 - GuruFocus.com
Where Will GlaxoSmithKline Go Next? 10:50 a.m. Dec. 24, 2013 - Wall St. Cheat Sheet
Dow Dogs Drink To A Dominant 2013. Will They Toast A Triumphant 2014, Too? 10:38 a.m. Dec. 24, 2013 - Seeking Alpha
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Patent Settlements, Stock Price Movements, and Financial Guidance - Research Report on Pfizer, Tenet, Rockwell Medical, Magellan Health Services, and HealthSouth 8:00 a.m. Dec. 20, 2013 - PR Newswire
FDA Accepts For Review ELIQUIS(R) (apixaban) Supplemental New Drug Application for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE 5:01 p.m. Dec. 19, 2013 - BusinessWire
Athersys Confirms Completion of Patient Enrollment of Pfizer's Phase II Study of MultiStem(R) Cell Therapy for Ulcerative Colitis 7:00 a.m. Dec. 19, 2013 - GlobeNewswire
Surgical Scar Market Is Ripe for Innovation 11:15 a.m. Dec. 18, 2013 - ACCESSWIRE
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
Teva Settles Viagra(R) Patent Litigation with Pfizer 4:35 p.m. Dec. 17, 2013 - BusinessWire
Pfizer Settles Viagra(R) Patent Litigation With Teva 11:55 a.m. Dec. 17, 2013 - BusinessWire
Pfizer Invites Public To View And Listen To Webcast Of January 28 Conference Call With Analysts 10:00 a.m. Dec. 17, 2013 - BusinessWire
Pfizer Names Albert Bourla Group President; Vaccines, Oncology and Consumer Healthcare Business 9:00 a.m. Dec. 17, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Pfizer Declares First-Quarter 2014 Dividend 11:20 a.m. Dec. 16, 2013 - BusinessWire
InvestorsObserver releases comments on Pfizer, Oracle, FedEx, Jabil Circuit, and Trulia 9:31 a.m. Dec. 16, 2013 - PR Newswire
Siemens Enters Into Master Agreement With Pfizer for Companion Diagnostics 9:26 a.m. Dec. 16, 2013 - BusinessWire
Critical Alerts For Pfizer, Halliburton, Joy Global, Anadarko Petroleum, and Hewlett Packard Released By InvestorsObserver 9:31 a.m. Dec. 12, 2013 - PR Newswire
Octapharma AG Enters into Agreement with Pfizer for the Future Commercialization and Marketing in the U.S. of an Investigational Intravenous Therapy for the Urgent Reversal of an Oral Anticoagulant 8:59 a.m. Dec. 11, 2013 - BusinessWire
Octapharma AG Enters into Agreement with Pfizer for the Future Commercialization and Marketing in the U.S. of an Investigational Intravenous Therapy for the Urgent Reversal of an Oral Anticoagulant 6:00 a.m. Dec. 11, 2013 - BusinessWire